Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.35% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.62% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
South Plains Financial
SPFI
$800M
| $833K | ﹤0.01% |
19,330
+633
| +3% | +$26.4K |
2022 Q1
17 quarters
|
|
2952
The RealReal
REAL
$1.61B
| $832K | ﹤0.01% |
70,540
-6,573
| -9% | -$70.1K |
2024 Q1
9 quarters
|
|
2953
Lightspeed Commerce
LSPD
$1.33B
| $830K | ﹤0.01% |
79,142
-2,691
| -3% | -$25.1K |
2021 Q1
21 quarters
|
|
2954
International Money Express
IMXI
$222M
| $829K | ﹤0.01% |
57,342
-5,503
| -9% | -$84.3K |
2021 Q1
21 quarters
|
|
|
CASK
2955
Sempreon, Inc. Common Stock
CASK
$380M
| $828K | ﹤0.01% |
47,271
-6,530
| -12% | -$119K |
2014 Q4
46 quarters
|
|
|
DMRA
2956
Damora Therapeutics
DMRA
$1.47B
| $826K | ﹤0.01% |
+31,774
| New | +$769K |
2026 Q2
0 quarters
|
|
2957
CytomX Therapeutics
CTMX
$477M
| $826K | ﹤0.01% |
220,205
+158,650
| +258% | +$606K |
2025 Q2
4 quarters
|
|
2958
Oppenheimer Holdings
OPY
$972M
| $823K | ﹤0.01% |
7,797
-15,135
| -66% | -$1.54M |
2025 Q3
3 quarters
|
|
2959
Cytek Biosciences
CTKB
$762M
| $823K | ﹤0.01% |
185,671
-202,562
| -52% | -$865K |
2022 Q1
17 quarters
|
|
2960
Vanguard Intermediate-Term Bond ETF
BIV
$28.7B
| $819K | ﹤0.01% |
10,678
+535
| +5% | +$41.1K |
2013 Q2
52 quarters
|
|
2961
Nature's Sunshine
NATR
$188M
| $818K | ﹤0.01% |
37,538
-9,631
| -20% | -$225K |
2023 Q4
10 quarters
|
|
2962
DELISTED
Talkspace
TALK
| $817K | ﹤0.01% |
157,038
+78,425
| +100% | +$407K |
2024 Q2
8 quarters
|
|
2963
Home Bancorp
HBCP
$474M
| $817K | ﹤0.01% |
11,917
+3,819
| +47% | +$247K |
2025 Q2
4 quarters
|
|
2964
Baytex Energy
BTE
$2.92B
| $807K | ﹤0.01% |
201,836
-174,683
| -46% | -$807K |
2023 Q1
13 quarters
|
|
2965
Septerna Inc
SEPN
$2.28B
| $807K | ﹤0.01% |
24,094
-58,774
| -71% | -$1.67M |
2024 Q4
6 quarters
|
|
2966
Columbia Financial
CLBK
$2.99B
| $804K | ﹤0.01% |
83,404
+8,677
| +12% | +$76.6K |
2019 Q1
29 quarters
|
|
2967
Savers
SVV
$1.51B
| $802K | ﹤0.01% |
79,450
+7,687
| +11% | +$66.7K |
2023 Q2
12 quarters
|
|
2968
FerroAtlántica
GSM
$478M
| $800K | ﹤0.01% |
251,691
-48,757
| -16% | -$202K |
2013 Q2
52 quarters
|
|
2969
Octave Specialty Group
OSG
$225M
| $798K | ﹤0.01% |
127,868
-23,174
| -15% | -$121K |
2015 Q1
45 quarters
|
|
2970
WEBTOON Entertainment Inc
WBTN
$1.31B
| $795K | ﹤0.01% |
69,632
+8,087
| +13% | +$95.7K |
2025 Q1
5 quarters
|
|
2971
Tyra Biosciences
TYRA
$1.45B
| $795K | ﹤0.01% |
24,893
-84,159
| -77% | -$2.78M |
2025 Q3
3 quarters
|
|
2972
Vodafone
VOD
$36.1B
| $794K | ﹤0.01% |
60,032
-10,548
| -15% | -$160K |
2022 Q3
15 quarters
|
|
2973
Akebia Therapeutics
AKBA
$111M
| $792K | ﹤0.01% |
694,928
-25,211
| -4% | -$30K |
2023 Q2
12 quarters
|
|
2974
Carriage Services
CSV
$426M
| $792K | ﹤0.01% |
20,650
-6,334
| -23% | -$277K |
2013 Q2
52 quarters
|
|
2975
ThredUp
TDUP
$170M
| $790K | ﹤0.01% |
115,347
+31,599
| +38% | +$148K |
2022 Q2
16 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.